Patient preference for and satisfaction with inhaler devices

European Respiratory Review

Volumn 14, Issue 96, 2005, Pages 109-116

  Anderson, P ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Inhaler; Preference; Satisfaction

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FENOTEROL; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; IPRATROPIUM BROMIDE; LONG ACTING DRUG; SALBUTAMOL; SHORT ACTING DRUG; TERBUTALINE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUSTRY; EVALUATION; FINANCIAL MANAGEMENT; HUMAN; INHALER; MEASUREMENT; METERED DOSE INHALER; PATIENT ATTITUDE; PATIENT GUIDANCE; PATIENT PREFERENCE; PATIENT SATISFACTION; PATIENT SELECTION; STANDARD; TREATMENT OUTCOME;

EID: 29744455597     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.05.00009606     Document Type: Conference Paper

References (34)

1. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127: 335-371.
2. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000; 94: 496-500.
3. Oliver S, Rees PJ. Inhaler use in chronic obstructive pulmonary disease. Int J Clin Pract 1997; 51: 443-445.
4. Moore AC, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus inhaler compared with the Handihaler. Int J Clin Pract 2004; 58: 444-450.
5. Schlaeppi M, Edwards K, Fuller RW, Sharma R. Patient perception of the Diskus inhaler: a comparison with the Turbuhaler inhaler. Br J Clin Pract 1996; 50: 14-19.
6. Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and acceptability of multidose dry powder inhalers: a randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002; 15: 59-64.
7. Sheth K, Bernstein JA, Lincourt WR, et al. Patient perceptions of an inhaled asthma medication administered as an inhalation powder via the Diskus or as an inhalation aerosol via a metered-dose inhaler. Ann Allergy Asthma Immunol 2003; 91: 55-60.
8. van der Palen J, Klein JJ, Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998; 35: 147-152.
9. Burdon J, Droszcz W, Jones R, Johnston PR, Trowell SJ. Comparison of efficacy and ease of handling of salmeterol and terbutaline powder inhalers. Int J Clin Pract 1998; 52: 85-88.
10. Pieters WR, Stallaert RA, Prins J, et al. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients. J Asthma 1998; 35: 337-345.
11. Mahajan P, Okamoto L. Patient satisfaction with the Diskhaler and the Diskus inhaler, a new multidose powder delivery system for the treatment of asthma. Clin Ther 1997; 19: 1126-1134.
12. Liam CK, Lim KH, Wong CM. Acceptance of the Accuhaler, a multi-dose powder inhaler, among asthmatic patients: a comparison with the pressurized metered-dose inhaler. Asian Pac J Allergy Immunol 2000; 18: 135-140.
13. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J Asthma 1995; 32: 429-436.
14. Boe J, Stiksa G, Svensson K, Asbrink E. New method of evaluating patient preference for different inhalation delivery systems. Ann Allergy 1992; 68: 255-260.
15. Osterman K, Stahl E, Kallen A. Bricanyl Turbuhaler in the treatment of asthma: a six week multi-centre study carried out in Sweden, the United Kingdom, Denmark, Norway and Finland. Eur Respir J 1991; 4: 175-179.
16. Osterman K, Norborg AM, Stahl E. A multiple dose powder inhaler (Turbuhaler) compared with a conventional aerosol. An acceptance study in asthmatics. Allergy 1989; 44: 294-297.
17. Engel T, Heinig JH, Malling HJ, et al. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler. Allergy 1989; 44: 220-225.
18. Campbell LM, Anderson TJ, Parashchak MR, et al. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group. Respir Med 1999; 93: 236-244.
19. Lindsay DA, Russell NL, Thompson JE, et al. A multicentre comparison of the efficacy of terbutaline Turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. Eur Respir J 1994; 7: 342-345.
20. Welch MJ, Nelson HS, Shapiro G, et al. Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. J Aerosol Med 2004; 17: 129-139.
21. Vilsvik JS, Ringdal N, Albrektsen T, Holthe S. Comparison of the acceptability of the Ventolin metered-dose inhaler and the Bricanyl Turbuhaler. Ann Allergy 1993; 70: 300-304.
22. Tjwa MK. Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Ann Allergy Asthma Immunol 1995; 75: 107-111.
23. Brown PH, Lenney J, Armstrong S, Ning AC, Crompton GK. Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists. Eur Respir J 1992; 5: 1143-1145.
24. Gioulekas D, Papakosta D, Vordoyianni P, Baloti H, Vamvalis C. A comparison of the clinical efficacy and patient acceptability of terbutaline Turbuhaler and salbutamol Rotahaler, in adult patients with asthma. Respir Med 1996; 90: 205-209.
25. Schurmann W, Schmidtmann S, Moroni P, Massey D, Qidan M. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med 2005; 4: 53-61.
26. Jager L, Laurikainen K, Leinonen M, Silvasti M. Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbohaler in the control of asthma and is preferred by patients. German Study Group. Int J Clin Pract 2000; 54: 368-372.
27. Kunkel G, Schaper C, Noga O, et al. Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder Inhaler or a standard CFC metered-dose inhaler in asthma patients. Respiration 2003; 70: 399-406.
28. Frew AJ, Langley SJ, Perrin V, Hertog MG. Effects of 4-week treatment with low-dose budesonide (100 micrograms BID) from a novel inhaler Airmax and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma. Respir Med 2002; 96: 542-547.
29. van Schayck CP, Bijl-Hofland ID, Folgering H, et al. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002; 20: 126-128.
30. Shieh WB. Preference for the Diskhaler rather than the metered dose inhaler in patients with airway obstruction. Changgeng Yi Xue Za Zhi 1994; 17: 20-27.
31. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004; 7: 204-215.
32. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004; 2: 12.
33. Kozma CM, Slaton TL, Monz BU, Hodder R, Reese PR. Development and validation of a patient satisfaction and preference questionnaire for inhalation devices. Treat Respir Med 2005; 4: 41-52.
34. Leidy N, Revicki D, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value in Health 1999; 2: 113-127.